BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 25, 2016
View Archived Issues
Navacims induce immune tolerance in mouse models of autoimmune disease
Read More
Renova Therapeutics receives NIH grant to support urocortin-2 gene therapy
Read More
Transferrin-targeted beta-amyloid antibody enables PET imaging in mouse model of AD
Read More
MiR-148a regulates B-cell tolerance and is a potential target in lupus
Read More
Autoantibody profiling can distinguish between lung cancer and benign nodules
Read More
F. Hoffmann-La Roche patents HBsAg inhibitors
Read More
Bayer Schering Pharma announces soluble guanylyl cyclase activators
Read More
Kissei Pharmaceutical patents tachykinin NK1 receptor antagonists for CINV
Read More
Janssen R&D Ireland unveils antiviral compounds against influenza virus
Read More
Merck & Co. discloses factor XIa inhibitors
Read More
Merus acquires rights in France to four launched drugs from Sanofi
Read More
Phenex receives milestone payment from Gilead for GS-9674 phase I program
Read More
Regen preparing IND for its novel siRNA NR2F6 checkpoint inhibitor
Read More
FDA accepts and grants priority review for sNDA for Avycaz
Read More
Omeros expands OMS-721 compassionate use program
Read More
Astellas seeks Japanese approval for linaclotide in IBS-C
Read More
Forty Seven reports on Series A financing to fund development of CD47 modulators
Read More
Teva returns U.S. rights to Adasuve to Alexza
Read More
Merganser Biotech initiates first clinical trial for M-012
Read More
EMA approves development strategy for Mologen's lefitolimod
Read More
Bayer initiates phase I trial of BAY-1251152 in patients with advanced cancer
Read More
Merck & Co. licenses basifungin derivatives from AureoGen
Read More
Small-molecule reveals novel mechanism of action for the treatment of colorectal cancer
Read More
Novartis initiates phase I trial of LXH-254 for advanced solid tumors with MAPK pathway alterations
Read More
Stemline Therapeutics starts phase I trial of exportin-1 inhibitor SL-801
Read More
